Praduman K. Tickoo, Vice President of Digital Manufacturing Services and Solutions at L&T Technology Services, will address how digital technologies are transforming the aerospace sector at the American Aerospace & Defense Summit 2018. Prior to the summit, we spoke with Praduman to discuss how aerospace companies can leverage technology and digitization to maximize their ROI and stay competitive in an ever-changing landscape. This is an excerpt from an interview Generis Group did with Praduman K. Tickoo prior to the American Aerospace & Defense Summit 2018.
Read More →Q&A with InDepth Engineering Solutions
This is an excerpt from an interview Generis Group did with InDepth Engineering Solutions, following the American Automotive Summit 2018. “The automotive industry is looking at a global skills shortage in which not enough engineers are sufficiently qualified to support the advancements of emerging technologies or operate sophisticated automated machinery. How does InDepth Engineering Solutions address this talent gap?
Read More →Ask the Expert: EU MDR
HCL hosted a Lunch & Learn Roundtable Discussion at the American Medical Device Summit 2018 last month in Chicago, IL. The session, “Ask the Expert – MDR and Lifecycle Management”, was led by Associate Vice President, Hilde Viroux. Hilde addressed questions surrounding the uncertainty of EUDAMED and UDI, the transition period, and how to obtain compliance. This is an excerpt from an interview Generis Group did with Hilde Viroux, AVP, Regulatory of HCL, America Inc. prior to the American Medical Device Summit 2018. “What are some of the biggest challenges in the new MDR that will impact device manufacturers? There are a lot of changes in the EU MDR that impact device manufacturers. Generating clinical data for all devices, developing the required reports and updating technical files to be compliant with Annex II and III is where most of the budget will typically go. In addition, there is the requirement to trace hazardous substances in devices and identify them on the label. The new regulation also requires manufacturers to set up a proactive approach to following the performance and safety of the device throughout its lifecycle.”
Read More →Interview with Frans Cronje, Managing Director & Co-founder, DataProphet
This is an excerpt from an interview Generis Group did with Frans Cronje, Managing Director & Co-founder of DataProphet prior to the American Automotive Summit 2018. “How does AI work with an existing production team to eliminate defects, scrap and minimize downtime? Our flagship product, OMNI, is a powerful process parameter optimization solution that significantly reduces waste in manufacturing processes. OMNI recommends optimal parameter values to the production team, enabling them to continuously improve the individual processes for which they are responsible.
Read More →LEADERS IN THE AUTOMOTIVE SUMMIT: INTERVIEW WITH FABIAN SCHMAHL
Fabian Schmahl was named President & CEO of thyssenkrupp Bilstein of America, Inc. in April 2008. He is responsible for managing the development and manufacture of premium quality, high performance automotive suspension solutions for Original Equipment, Aftermarket and Motorsports applications. Schmahl oversees the operations of thyssenkrupp Bilstein locations in Hamilton, Ohio (headquarters); Poway, California; Troy, Michigan; and Mooresville, North Carolina. As President & CEO of thyssenkrupp Bilstein, Schmahl has earned extensive recognition for his commitment to his employees, community and the manufacturing industry. Under his leadership, thyssenkrupp Bilstein has been recognized as a Top Workplace in 2010, 2011, 2012 and 2013 by Enquirer Media and Best Workplace in 2010, 2011, 2012 and 2013 by Business Courier. In 2015 and 2017, Butler County Board of Developmental Disabilities voted thyssenkrupp Bilstein of America Employer of the Year. In November, Fabian will join us at the American Automotive Summit.
Read More →“The Future is Bright” – Reflections on the American Biomanufacturing Summit
Tawni Koutchesfahani, Director of Supply Chain at Relypsa, recently attended our 2018 American Biomanufacturing Summit. One of her key takeaways from the event was around how the paradigm of manufacturing and QA operations is changing and the ways in which it needs to change. We asked her to share her thoughts on the Generis blog. The Future is Bright By Tawni Koutchesfahani, Director of Supply Chain, Relypsa Let’s take a step back and think about where we were 38 years ago. In 1980, Martin Cline made the first attempt to modify human DNA. By 1989, National Institutes of Health approved the first nuclear gene transfer in humans. Since 1989, there have been over 2,000 clinical trials completed. If we fast forward to where we are now, gene therapy is now being viewed as the key to our future for many therapies. Last year, the industry hit some key milestones. Kite Pharma received its approval with Yescarta, and Novartis succeeded with Kymriah. Though these are significant highlights, the past addresses rare diseases. In turn, manufacturing of the gene therapy meets the market for a small population. As these therapies get approval for commercialization, the manufacturing models are not currently made for large scale, which poses a threat for the market. Thus, the whole notation of how we have been manufacturing has to change. How we have been producing in GMP environments has to change. How we have been implementing our quality systems …
Read More →Q&A with Intermex Industrial Parks: Sourcing Challenges and Solutions for Manufacturers in North America
In this Q&A eBook, find out how to thrive in an industry where production costs are soaring and the competition is cutthroat. Also, learn how to become a lean organization, thrive in a fast-paced world, enhance quality, and apply strategic sourcing operations. If North American manufacturers want to outsource, leaders have to change their mindset to adapt to a worldwide view and use geographic diversity to their advantage. When a company is doing well and the idea of change comes up, it may be difficult to allow that in a culture of complacency. -Intermex Find out more about sourcing challenges and solutions for manufacturers in North America from Intermex in the Q&A eBook below!
Read More →- Page 2 of 2
- 1
- 2